Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print August 2, 2002, 10.1148/radiol.2243011048
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2243011048v1
224/3/695    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, V. B.
Right arrow Articles by Choyke, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, V. B.
Right arrow Articles by Choyke, P. L.
(Radiology 2002;224:695-700.)
© RSNA, 2002


Genitourinary Imaging

Renal Masses: Quantitative Assessment of Enhancement with Dynamic MR Imaging1

Vincent B. Ho, MD, Scott F. Allen, Maureen N. Hood, BSN, RN and Peter L. Choyke, MD

1 From the MR Research Division, Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20814-4799 (V.B.H., M.N.H., P.L.C.); and Department of Diagnostic Radiology, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Md (V.B.H., S.F.A., M.N.H., P.L.C.). Received June 14, 2001; revision requested July 6; final revision received February 14, 2002; accepted March 12. Address correspondence to V.B.H. (e-mail: vho@usuhs.mil or vho@nih.gov).

PURPOSE: To establish a quantitative magnetic resonance (MR) imaging contrast enhancement criterion for distinguishing cysts from solid renal lesions.

MATERIALS AND METHODS: Regions of interest were measured in 74 patients with renal lesions evaluated by means of dynamic contrast material–enhanced MR imaging with serial breath-hold spoiled gradient-echo acquisitions. Sensitivity for renal tumors and specificity for renal cysts were established by using percentage of enhancement thresholds that varied between 5% and 35%.

RESULTS: The mean percentage of enhancement at MR imaging for the 50 renal cysts was less than 5%; for the 50 renal tumors, it was 97% or higher. With use of a threshold percentage of enhancement of 15% and results obtained between 2 and 4 minutes after administration of contrast material, all malignancies (sensitivity for tumor, 100%) were diagnosed, and there were 6% or fewer false-positive tumor diagnoses. Lower thresholds resulted in unacceptably high false-positive rates (ie, cysts that appeared to enhance—pseudoenhancement), whereas higher threshold values (>20%) resulted in an unacceptably lower sensitivity for tumors.

CONCLUSION: The optimal percentage of enhancement threshold for distinguishing cysts from malignancies with the imaging technique prescribed was 15%, and the optimal timing for measurement was 2–4 minutes after administration of contrast material.

© RSNA, 2002

Index terms: Kidney, cysts, 81.311 • Kidney, MR, 81.121411, 81.121412, 81.121415, 81.121416, 81.12143 • Kidney neoplasms, 81.311, 81.32 • Magnetic resonance (MR), contrast enhancement, 81.12143




This article has been cited by other articles:


Home page
RadiologyHome page
J. Zhang, Y. Mazaheri Tehrani, L. Wang, N. M. Ishill, L. H. Schwartz, and H. Hricak
Renal Masses: Characterization with Diffusion-weighted MR Imaging--A Preliminary Experience
Radiology, May 1, 2008; 247(2): 458 - 464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. P. Lokken, D. A. Gervais, R. S. Arellano, K. Tuncali, P. R. Morrison, S. Tatli, P. R. Mueller, and S. G. Silverman
Inflammatory Nodules Mimic Applicator Track Seeding After Percutaneous Ablation of Renal Tumors
Am. J. Roentgenol., October 1, 2007; 189(4): 845 - 848.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. G. Silverman, K. J. Mortele, K. Tuncali, M. Jinzaki, and E. S. Cibas
Hyperattenuating Renal Masses: Etiologies, Pathogenesis, and Imaging Evaluation
RadioGraphics, July 1, 2007; 27(4): 1131 - 1143.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
G. M. Israel and M. A. Bosniak
How I Do It: Evaluating Renal Masses
Radiology, August 1, 2005; 236(2): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
D. S. Hartman, P. L. Choyke, and M. S. Hartman
From the RSNA Refresher Courses: A Practical Approach to the Cystic Renal Mass
RadioGraphics, October 1, 2004; 24(suppl_1): S101 - S115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Tuncali, E. vanSonnenberg, S. Shankar, K. J. Mortele, E. S. Cibas, and S. G. Silverman
Evaluation of Patients Referred for Percutaneous Ablation of Renal Tumors: Importance of a Preprocedural Diagnosis
Am. J. Roentgenol., September 1, 2004; 183(3): 575 - 582.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. M. Hecht, G. M. Israel, G. A. Krinsky, W. Y. Hahn, D. C. Kim, I. Belitskaya-Levy, and V. S. Lee
Renal Masses: Quantitative Analysis of Enhancement with Signal Intensity Measurements versus Qualitative Analysis of Enhancement with Image Subtraction for Diagnosing Malignancy at MR Imaging
Radiology, August 1, 2004; 232(2): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
G. M. Israel and M. A. Bosniak
Follow-Up CT of Moderately Complex Cystic Lesions of the Kidney (Bosniak Category IIF)
Am. J. Roentgenol., September 1, 2003; 181(3): 627 - 633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2002 by the Radiological Society of North America.